Search results
Results from the WOW.Com Content Network
Most of the adverse effects stated in this list are associated with only a small percentage of cases; they should be understood as potential risks rather than as certainties. Herbs, treatments, and constituents with known or suspected adverse effects
Marshmallow roots. The leaves, flowers and the root of A. officinalis (marshmallow) have been used in traditional herbal medicine. This use is reflected in the name of the genus, which comes from the Greek ἀλθαίνειν (althainein), meaning "to heal".
Half the dogs received bedinvetmab and half the dogs received a sterile saline injection every 28 days for a total of three doses. [5] Before treatment and on various days throughout the study, owners used the Canine Brief Pain Inventory (CBPI) assessment tool to measure the severity of the dog's pain and the degree to which the pain interfered ...
Dangerous side effects from the injectable canine drug Librela — used to treat osteoarthritis joint pain — have been linked to seizures, lameness and loss of muscle control, the FDA warned.
The FDA has released a list of the people foods that, when fed to dogs, present a high risk of problems. SEE ALSO: Adorable French bulldog cools down from the summer heat
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). [7] It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. [7]
Malva parviflora is an annual or perennial herb that is native to Northern Africa, Southern Europe, and Western and Central Asia and is widely naturalized elsewhere. [2] ...
In September 2004, Merck voluntarily withdrew rofecoxib from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use. Merck withdrew the drug after disclosures that it withheld information about rofecoxib's risks from doctors and patients for over five years, allegedly resulting ...